GlassScriptPhysician profile
Peter T Kennealey
NPI 1073718680
$30,629.46
in general payments reported to CMS, 2019-2025
6 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,000 · 2020: $2,176 · 2021: $5,783 · 2022: $18K · 2024: $112 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veloxis Pharmaceuticals, INC. | $25,139.42 | 2020-2022 | |
| Artegraft INC. | $5,000.00 | 2019-2020 | |
| Ethicon US, LLC | $148.40 | 2025 | Surgicel Nu-Knit |
| W. L. Gore & Associates, INC. | $131.08 | 2022 | |
| Medtronic, INC. | $112.29 | 2024 | Endo Gia Ultra |
| Lemaitre Vascular, INC. | $98.27 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kennealey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.